Sun Pharma Advanced Research signs licensing deal with Biomodifying
Sun Pharma Advanced Research Company (SPARC) has signed an agreement with US-based Biomodifying for the exclusive licensing of the latter’s intellectual property (IP), including all patents and patent applications owned or controlled by it in addition to antibodies developed for various uses including for cancer. The India-based clinical stage biopharma company, which is owned by […]